Efficacy of second-line chemotherapy after treatment with gemcitabine plus nab-paclitaxel or FOLFIRINOX in patients with metastatic pancreatic cancer.
Fukahori M, Okabe Y, Shimokawa M, Otsuka T, Koga F, Ueda Y, Nakazawa J, Komori A, Otsu S, Arima S, Makiyama A, Taguchi H, Honda T, Ushijima T, Miwa K, Shibuki T, Nio K, Ide Y, Ureshino N, Mizuta T, Mitsugi K, Shirakawa T.
Fukahori M, et al. Among authors: miwa k.
Sci Rep. 2023 Nov 8;13(1):19399. doi: 10.1038/s41598-023-46924-0.
Sci Rep. 2023.
PMID: 37938630
Free PMC article.